晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

交易中 11-02 15:01:22

6.005

-0.110

-1.80%

最高6.185	最低5.780	成交量4,668万
今开6.135	昨收6.115	日振幅6.62%
总市值258.03亿	流通市值258.03亿	总股本42.97亿
成交额2.78亿	换手率1.09%	流通股本42.97亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":6.005,"timestamp":1793602879868,"preClose":6.115,"halted":0,"volume":46677656,"delay":0,"changeRate":-0.017988552739166035,"floatShares":4297000000,"shares":4297000000,"eps":0.03,"marketStatus":"交易中","change":-0.11,"latestTime":"11-02 15:01:22","open":6.135,"high":6.185,"low":5.78,"amount":277974987,"amplitude":0.066231,"askPrice":6.015,"askSize":98000,"bidPrice":6,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.057,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793607000000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":6.115,"openAndCloseTimeList":[[1793583000000,1793592000000],[1793595600000,1793606400000]],"volumeRatio":1.620927,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"TPX.HK","impliedVol":0.6557,"impliedVolPercentile":0.7442},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"1132716704","title":"异动解读｜晶泰控股盘中下跌5.07%，报5.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132716704","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132716704?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:57","pubTimestamp":1793584648,"startTime":"0","endTime":"0","summary":"11月2日，晶泰控股盘中下跌5.07%，报5.81港元，成交额8562.67万港元。晶泰控股所在的生命科学工具和服务行业中，药明康德下跌4.1%，金斯瑞生物-一千下跌3.54%，药明生物下跌3.69%，药明合联下跌4.5%，英矽智能下跌2.67%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680786312","title":"【券商聚焦】中信建投：中国医药资产全球性价比凸显，内外协同空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786312","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786312?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:46","pubTimestamp":1793580413,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券发布研报称，2026年欧洲内科肿瘤学会 中，中国创新药在多瘤种领域全面发力，众多项目从早期探索迈入III期临床或BLA/NDA阶段。该机构指，中国医药具有“创新升级+供应链韧性”优势，2025年创新药海外授权首付款大幅超去年全年，器械也在积极探索出海路径。美国主导早期研发与高端定价，但跨国药企专利悬崖下需求旺盛，中国资产全球性价比凸显，内外协同空间广阔。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0348825331.USD","02367","BK1141","LU0634319403.HKD","01530","01789","SG9999014674.SGD","LU1251922891.USD","02196","LU0588546209.SGD","BK1100","LU2476274308.USD","LU2399975544.HKD","01099","03933","BK1161","IE00BPRC5H50.USD","06821","LU2476274720.SGD","LU0540923850.HKD","LU0561508036.HKD","IE00B5MMRT66.SGD","09926","KCE","LU0307460666.USD","BK1588","LU1720050803.USD","BK1610","SG9999004311.SGD","BK1207","LU0348735423.USD","601066","BK1617","BK0188","600056","LU0348783233.USD","LU2488822045.USD","LU0417516902.SGD","LU0348767384.USD","02268","02228","06160","BK0028","BK1515","LU1969619763.USD","LU0228659784.USD","09688","03069","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679479325","title":"晶泰控股与新加坡科技研究局签署合作备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2679479325","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679479325?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:17","pubTimestamp":1793265420,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯(记者王墨璞嘉)10月28日，晶泰控股与新加坡科技研究局(A*STAR)在新加坡创新科技周(SWITCH2026)期间签署合作备忘录(MOU)。晶泰控股将作为新加坡材料创新计划MARVEL-AI的技 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681248180.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681248180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1141","BK1617","02228","STmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677926041","title":"晶泰控股(02228)根据股份计划发行22.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677926041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677926041?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:14","pubTimestamp":1792754045,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)发布公告，于2026年10月23日根据股份计划发行22.5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141724063","title":"晶泰控股：10月23日发行225,000股新股，已发行股本变动约0.0052%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141724063","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141724063?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:11","pubTimestamp":1792753882,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年10月23日发布公告，宣布根据其董事受限制股份单位计划，发行225,000股新股，约占发行前已发行股本的0.0052%。本次发行每股价格为0.00001美元。公告显示，于本次发行前，公司于2026年10月22日的已发行股份总数为4,296,294,179股，库藏股299,000股。公司进一步表示，本次发行已获得董事会正式授权，相关程序均符合香港联合交易所有限公司证券上市规则及其他适用法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"晶泰控股：10月23日发行225,000股新股，已发行股本变动约0.0052%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161154215","title":"晶泰控股三度回购合计488.20万股，耗资约3743.02万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161154215","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161154215?lang=zh_cn&edition=full","pubTime":"2026-10-22 19:26","pubTimestamp":1792668361,"startTime":"0","endTime":"0","summary":"晶泰控股 (02228) 于2026年10月22日公告，公司于2026年9月11日、10月2日及10月5日分别回购并于同日注销合计488.20万股普通股，占回购前公司已发行股本约0.1135%，回购价格介乎每股6.8883港元至7.8999港元，合计涉资约3743.02万港元。\n本次回购完成后，公司已发行股本由原有的约43.01亿股减少至约42.96亿股；公司库存股为29.90万股，总股本则降至约42.97亿股。公司确认，回购行为已获得董事会正式授权，并遵守了香港联交所证券上市规则及相关法例的规定。公告由公司董事温书豪博士签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"晶泰控股三度回购合计488.20万股，耗资约3743.02万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677957499","title":"晶泰控股(02228.HK)10月22日注销488.2万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2677957499","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677957499?lang=zh_cn&edition=full","pubTime":"2026-10-22 19:23","pubTimestamp":1792668211,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188278644","title":"异动解读｜晶泰控股盘中下跌5.08%，创新药板块回调拖累情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1188278644","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188278644?lang=zh_cn&edition=full","pubTime":"2026-10-22 14:59","pubTimestamp":1792652371,"startTime":"0","endTime":"0","summary":"10月22日，晶泰控股盘中下跌5.08%，报5.795港元，成交额2.28亿港元。当日创新药相关板块明显分化并整体承压，带动生命科学工具和服务个股走弱。同行中，药明生物跌9.76%，药明合联跌9.59%，英矽智能跌7.56%，药明康德跌6.22%，金斯瑞生物-一千跌6.0%。此前公司股价曾受主席温书豪于10月7日至10月15日累计增持379.3万股、耗资约2500万港元，以及关联方于10月15日增持100万股、涉资约590.51万港元提振；但在板块回调背景下，相关增持消息对当日股价支撑有限。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"创新药板块集体回调，晶泰控股承压走低","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677367328","title":"QuantumPharm Holdings Limited增持晶泰控股(02228)100万股 每股作价5.9051港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677367328","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677367328?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:02","pubTimestamp":1792580559,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，10月15日，QuantumPharm Holdings Limited增持晶泰控股(02228)100万股，每股作价5.9051港元，总金额为590.51万港元。增持后最新持股数目约为6.61亿股，最新持股比例为15.37%。本交易涉及其他关联方：TMF (Cayman) Ltd.、WSH Family Holdings Limited、温书豪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510273.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228","BK1617","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665575","title":"创新药概念强势 翰森制药（03692）涨逾7% 前三季对外技术授权约1300亿美元接近25年全年","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665575","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665575?lang=zh_cn&edition=full","pubTime":"2026-10-20 11:23","pubTimestamp":1792466598,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念强势，截至发稿，乐普生物 涨8.81%，翰森制药涨7.06%，药明生物涨6.74%，晶泰控股涨4.56%，康诺亚-B涨4.70%，亚盛医药涨4.30%，恒瑞医药涨4.16%，药明合联涨3.96%，云顶新耀涨3.89%，和黄医药涨3.68%，中国生物制药涨3.24%，石药集团涨3.16%，科伦博泰生物涨3.14%，诺诚健华涨3.08%。消息面上，据人民财讯，10月20日，国家发展改革委召开10月份新闻发布会，会上提到，我国前三季度创新药对外技术授权约1300亿美元，接近去年全年。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993987","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","BK1610","LNGR","LU1152091754.HKD","BK1589","LU1188198961.HKD","KURE","01276","06855","BK1576","LU1008478684.HKD","LU0359201885.HKD","03692","MEDX","LU1242518857.USD","IBBQ","00013","LU1242518931.SGD","LU1720050803.USD","LU0128522744.USD","LU0588546209.SGD","LU2543165471.USD","06990","LU0211977185.USD","LU0196878994.USD","LU0348827113.USD","02157","02162","06978","LU1993786604.SGD","LU0417516738.SGD","LU2488822045.USD","LU0072913022.USD","LU0043850808.USD","LU1794554557.SGD","IE0008369823.USD","LU1226288170.HKD","LU0052750758.USD","LU0979878070.USD","01093","159992","LU0417516902.SGD","BK1521","02228","02269","01952","01177","BK1161","LU2476274720.SGD","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676329616","title":"晶泰控股(02228.HK)：董事会主席温书豪增持合共379.3万股 总代价2500万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676329616","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676329616?lang=zh_cn&edition=full","pubTime":"2026-10-20 07:59","pubTimestamp":1792454362,"startTime":"0","endTime":"0","summary":"格隆汇10月20日丨晶泰控股(02228.HK)发布公告，有关董事会主席、执行董事兼公司联合创始人温书豪博士计划增持公司股份，董事会获温博士告知，其已于2026年10月7日至10月15日期间动用自有资金，透过公开市场交易购入合共379.3万股股份(包括于2026年10月7日购入的130万股股份)，占公司全部已发行股份约0.09%，总代价约2500万港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261020/32401559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164105603","title":"晶泰控股（02228）披露董事会主席再度增持 共耗资2,500万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164105603","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164105603?lang=zh_cn&edition=full","pubTime":"2026-10-20 06:15","pubTimestamp":1792448137,"startTime":"0","endTime":"0","summary":"10月20日，晶泰控股有限公司发布自愿性公告称，董事会主席、执行董事兼联合创始人温书豪博士已于2026年10月7日至10月15日期间，通过公开市场合计购入公司3,793,000股普通股，增持金额约为2,500万港元。上述股份占公司已发行股份总数约0.09%。公司表示，温书豪博士计划在符合法律及监管要求的前提下，视市场情况和个人投资计划继续增持。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676631183","title":"晶泰控股(02228.HK)获董事会主席温书豪增持合共379.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676631183","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676631183?lang=zh_cn&edition=full","pubTime":"2026-10-20 06:14","pubTimestamp":1792448062,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156788436","title":"异动解读｜晶泰控股盘中下跌5.45%，AI制药板块回调延续拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1156788436","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156788436?lang=zh_cn&edition=full","pubTime":"2026-10-15 13:25","pubTimestamp":1792041918,"startTime":"0","endTime":"0","summary":"10月15日，晶泰控股盘中下跌5.45%，报5.9港元，成交额2.29亿港元。消息面上，港股AI制药及创新药相关个股延续回调，板块承压对晶泰控股形成直接拖累。同板块中，英矽智能跌8.85%，金斯瑞生物跌8.9%，药明合联、药明生物亦走弱。尽管董事会主席近期先后增持130万股和99.3万股，公司亦有回购动作，但短线未扭转调整趋势。晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"晶泰控股盘中走低，AI制药板块回调拖累","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675351426","title":"董事会主席温书豪增持晶泰控股(02228)99.3万股 每股作价约6.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675351426","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675351426?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:13","pubTimestamp":1791889986,"startTime":"0","endTime":"0","summary":"10月9日，董事会主席温书豪增持晶泰控股(02228)99.3万股，每股作价6.8908港元，总金额约为684.26万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20261013/20261013191338_91388.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261013/20261013191338_91388.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1617","02228","BK1141","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157830362","title":"港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157830362","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157830362?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:38","pubTimestamp":1791855517,"startTime":"0","endTime":"0","summary":"10月13日，港股创新药概念股集体走低，$华昊中天医药-B(02563)$跌超11%，$金斯瑞生物科技(01548)$跌超10%，$药明合联(02268)$、$晶泰控股(02228)$跌超4%，$药明生物(02269)$、$歌礼制药-B(01672)$跌超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","LU1794554557.SGD","BK1515","LU0228659784.USD","LU0348827113.USD","LU0051755006.USD","HK0000306701.USD","LU0572944931.SGD","LU1720050803.USD","LU3063872942.SGD","LU1242518857.USD","IE00B0JY6N72.USD","LU0708995583.HKD","BK4585","LU0417516902.SGD","02563","LU0039217434.USD","01672","LU0307460666.USD","BK1521","LU1188198961.HKD","SG9999002463.SGD","HK0000320223.HKD","BK1583","IBBQ","01548","09939","06978","LU0456827905.SGD","LU0359202008.SGD","LU0516423174.USD","LU2778985437.USD","LU0463099449.HKD","LU0516422952.EUR","LU0359201612.USD","02228","BK1589","LU0823426480.USD","BK1610","KCAI","02269","LU0516422366.SGD","VXUS","BK1161","LU0516422440.USD","LU0140636845.USD","LU2476274720.SGD","LU0348825331.USD","LU0348735423.USD","LU0211977185.USD","LU0819121731.USD","LU2476274308.USD","LU0979878070.USD","SG9999002562.SGD","BK4588","LU0052750758.USD","LU0244354667.USD","LU0561508036.HKD","LU0540923850.HKD","LU0128526141.USD","LU0823426308.USD","LU0516423091.SGD","MEDX","LU1880383366.USD","LU0856984785.SGD","LU0320764599.SGD","LU0029874905.USD","LU0828237510.HKD","LU0128522744.USD","LU0326950275.SGD","LU1688375341.USD","LU0320764243.SGD","HK0000320264.USD","LU0043850808.USD","BK1617","LU0708995153.HKD","LU0456846285.SGD","BK1576","LU1831875114.USD","LU0327786744.USD","KURE","LU2039709279.SGD","LU0181495838.USD","SG9999014674.SGD","01477","LU0029874061.USD","HK0000306685.HKD","BK1141","LU0634319403.HKD","LU2488822045.USD","LU1242518931.SGD","LNGR","LU0417516738.SGD","LU0588546209.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112170297","title":"异动解读｜晶泰控股盘中下跌5.08%，AI制药板块集体回调拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1112170297","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112170297?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:37","pubTimestamp":1791855467,"startTime":"0","endTime":"0","summary":"10月13日，晶泰控股盘中下跌5.08%，报6.55港元，成交额5545.01万港元。消息面上，港股AI制药板块延续节后回调态势，板块内个股普遍走弱，晶泰控股作为AI制药核心标的随之承压。行业个股中，金斯瑞生物科技跌10.06%，英矽智能跌5.66%，药明合联跌4.06%，药明生物跌3.04%，药明康德跌1.92%，生命科学工具及AI制药标的全线走低。此前板块连续上涨后获利盘集中了结，叠加海外生物医药板块风险偏好下行，资金从高估值创新药标的撤离，拖累晶泰控股股价表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AI制药板块集体回调，晶泰控股随势下行","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675864833","title":"Lloyd S. Miller博士任Ailux首席医学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2675864833","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675864833?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:37","pubTimestamp":1791851870,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1617","02228","HELX","WDNA","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185944999","title":"异动解读｜晶泰控股盘中下跌5.04%，创新药板块集体回调拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1185944999","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185944999?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:21","pubTimestamp":1791512464,"startTime":"0","endTime":"0","summary":"10月9日，晶泰控股盘中下跌5.04%，报6.785港元，成交额2.79亿港元。消息面上，创新药板块节后整体承压，港股生命科学工具及AI制药标的普遍走弱，板块联动效应明显。行业个股中，药明生物跌3.05%，药明康德跌3.45%，金斯瑞生物科技跌2.26%，英矽智能跌2.36%，药明合联跌3.53%。此前板块经历连续上涨后获利盘集中了结，叠加海外生物医药板块风险偏好下行，资金从高估值创新药标的撤离，晶泰控股作为AI制药核心标的随之调整。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"创新药板块集体回调，晶泰控股承压走低","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674611884","title":"人工智能板块走低 纳芯微（02676）跌8.07% OpenAI年化收入逊于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2674611884","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674611884?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:37","pubTimestamp":1791509850,"startTime":"0","endTime":"0","summary":"金吾财讯 | 人工智能板块走低，纳芯微 跌8.07%，胜宏科技跌5.37%，海光芯正跌4.24%，英诺赛科跌4.19%，长飞光纤光缆跌3.88%，澜起科技跌4.02%，天数智芯跌3.85%，广合科技跌3.91%，晶泰控股跌3.36%，剑桥科技跌3.61%，飞速创新跌3.35%。消息面上，据报道，OpenAI截至9月底年化收入接近500亿美元，较上月多个媒体所报道数字，低约200亿美元。报道提到，差异在于OpenAI与竞争对手Anthropic的计算方法不同，Anthropic将透过合作伙伴AWS及GoogleCloud等销售的收入也计算在内，OpenAI则不包括这类合作伙伴收入。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993367","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUSE","TARK","QID","CHAT","01989","PSQ","MFIG","NEWZ","SQQQ","NJAN","06869","01191","DQJN","02676","TQQY","688052","PBOT","03355","CWC","02476","KOMP","GK","06166","AQGX","06809","AIBU","FWD","09903","QQQM","TQQQ","AIQU","NJUL","OGIG","MVPS","NBDS","AGIX","WPAI","QTOC","QQA","02577","02228","AIFD","ARTY","TECY","QQQ","CPNQ","161631","QSWN","LCLG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.2524},{"period":"3month","weight":-0.106},{"period":"6month","weight":-0.3583},{"period":"1year","weight":-0.4608},{"period":"ytd","weight":-0.3536}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0536},{"period":"3month","weight":-0.1001},{"period":"6month","weight":-0.0963},{"period":"1year","weight":-0.1137},{"period":"ytd","weight":-0.0911}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务主要包括早期苗头化合物生成到研究性新药的开发阶段，为临床试验的启动提供研究。智能机器人解决方案主要包括固态研发服务及自动化化学合成服务等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}